Medical devices, healthcare technology and the business of care
510(k) clearance · K261938

APRO 88 Catheter

Alembic, LLC · Decision date Oct 6, 2026

MEDTECHLEDGER EXPLANATIONK261938

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 2026-10-06 for the APRO 88 Catheter, submitted by Alembic, LLC of Mountain View, California, under 510(k) number K261938. The device falls under regulation 870.1250 with the classification name Catheter, Percutaneous, Neurovasculature, primary product code QJP and subsequent product code DQY. The regulation medical specialty is listed as Cardiovascular, while the 510(k) review panel is Neurology. The application was received 06/10/2026 as a Traditional 510(k), was not reviewed by a third party, and was not a combination product.

SESE means FDA cleared the submission as substantially equivalent to a legally marketed predicate device; it is not a PMA approval. The public record does not identify the predicate device, the specific components or materials, or any indications for use, and no summary or decision statement is included in the available text. A Predetermined Change Control Plan was not authorized, so no pre-authorized modification scope is recorded. The same decision appears in FDA's final-decision listing dated 06 October 2026.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Oct 6, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261938
Regulatory pathway
510(k) premarket notification
Applicant
Alembic, LLC
Product code
QJP
Decision code
SESE
Decision date
Oct 6, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Catheter, Percutaneous, Neurovasculature.

Applicant
Alembic, LLC
Product code
QJP
FDA device class
2

FDA decision timeline

  1. K261938 received

    Application receipt date recorded by FDA.

  2. K261938 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code QJP

Product / regulatory recordCompanyPathwayDecision dateSource
Perfuze, Ltd.510(k) clearanceNov 5, 2026FDA
Stryker Neurovascular510(k) clearanceOct 9, 2026FDA
Cognition Medical Corp.510(k) clearanceOct 2, 2026FDA
Route 92 Medical, Inc.510(k) clearanceSep 16, 2026FDA
Piraeus Medical, Inc.510(k) clearanceSep 4, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Alembic, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Mountain View, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records